Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors to Decrease the Risk of Cardiovascular Diseases: A Systematic Review

Cardiovascular disorders are one of the most frequent causes of death in people throughout the world. These disorders can account for the deaths of 31% of people worldwide. This systematic review examines the effectiveness of sodium-glucose cotransporter 2 (SGLT2) inhibitors in lowering the likeliho...

Descripción completa

Detalles Bibliográficos
Autores principales: Moparthi, Kiran Prasad, Al Rushaidi, Majdah T, Muddam, Meghana Reddy, Obajeun, Omobolanle A, Abaza, Abdelrahman, Jaramillo, Arturo P, Sid Idris, Faten, Anis Shaikh, Humna, Vahora, Ilma, Nath, Tuheen Sankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457136/
https://www.ncbi.nlm.nih.gov/pubmed/37638274
http://dx.doi.org/10.7759/cureus.44054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457136/
https://www.ncbi.nlm.nih.gov/pubmed/37638274
http://dx.doi.org/10.7759/cureus.44054

Ejemplares similares